Review Highlights Role of Ubiquitin-Proteasome System in Sensorineural Hearing Loss

A systematic review outlines how the ubiquitin-proteasome system governs auditory proteostasis and proposes targeting this pathway to address sensorineural hearing loss.

A peer-reviewed paper published in Molecular Biomedicine systematically maps the role of the ubiquitin-proteasome system (UPS) in the cochlea.

The authors characterized how E1/E2/E3 ubiquitin ligases, deubiquitinating enzymes, and proteasome subunits govern cochlear development and auditory function.

The review identifies the UPS as a central regulatory hub linking multiple pathological pathways involved in sensorineural hearing loss, including mitophagy, autophagy, oxidative stress, DNA damage repair, endoplasmic reticulum-associated degradation, and NF-κB-mediated inflammation.

Sensorineural hearing loss affects billions of people globally and is marked by the irreversible degeneration of cochlear hair cells, for which no restorative therapies exist.

By framing UPS-mediated proteostasis as a convergent pathway, the review links inner-ear pathologies directly to fundamental geroscience mechanisms like autophagy and mitophagy.

Identifying tissue-specific functional divergence of the UPS among cochlear structures lays the groundwork for utilizing cochlear cell-specific ubiquitinomics to design targeted therapeutic interventions.

The academic review does not present clinical validation but offers a conceptual blueprint that may expand the therapeutic applicability of existing proteostasis platforms.

Early-stage platforms focusing on cellular clearance mechanisms like autophagy and mitophagy may see expanded strategic optionality if these pathways are validated in inner-ear degenerative models.

The initiation of preclinical studies evaluating UPS-targeted small molecules or genetic interventions in animal models of age-related hearing loss.